Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Endocrinology|January 10, 2020
Increased number of retinal vessels in acromegalyLaila Füchtbauer, Daniel S Olsson, Eva C Coopmans, et al.
Journal of Neuro-Oncology|January 10, 2023
Healthcare utilization and costs among intracranial meningioma patients during long-term follow-upKevin A Huynh, Eva C Coopmans, Amir H Zamanipoor Najafabadi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2021
Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter StudyEva C Coopmans, Mark R Postma, Thalijn L C Wolters, et al.
The Journal of Clinical Endocrinology and Metabolism|October 23, 2018
Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 ExpressionAmmar Muhammad, Eva C Coopmans, Federico Gatto, et al.
European Journal of Endocrinology|May 7, 2020
T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegalyEva C Coopmans, Joppe J Schneiders, Nour El-Sayed, et al.
Endocrine|April 26, 2020
The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) studyE C Coopmans, A Muhammad, A F Daly, et al.
European Journal of Endocrinology|August 5, 2018
Efficacy and Safety of switching to Pasireotide in Acromegaly Patients controlled with Pegvisomant and Somatostatin Analogues: PAPE extension studyAmmar Muhammad, Eva C Coopmans, Patric J D Delhanty, et al.
Endocrine|April 26, 2020
Soluble Klotho: a possible predictor of quality of life in acromegaly patientsEva C Coopmans, Nour El-Sayed, Jan Frystyk, et al.
European Journal of Endocrinology|June 6, 2019
Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinomaEva C Coopmans, Sebastiaan W F van Meyel, Kay J Pieterman, et al.
Frontiers in Immunology|September 24, 2019
Endocrine Disorders Are Prominent Clinical Features in Patients With Primary Antibody DeficienciesEva C Coopmans, Paweena Chunharojrith, Sebastian J C M M Neggers, et al.
Pageof 3